Leishmania infantum lipophosphoglycan induced-Prostaglandin E2 production in association with PPAR-γ expression via activation of Toll like receptors-1 and 2

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Lima, Jonilson Berlink ^a,b   Araújo Santos, Théo ^a,b   Lázaro Souza, Milena ^a,c   Carneiro, Alan Brito ^a   Ibraim, Izabela Coimbra ^a   Jesus Santos, Flávio Henrique ^a,c   Luz, Nívea Farias ^a   Pontes, Sara De Moura ^a,c   Entringer, Petter Franco ^d   Descoteaux, Albert ^e   Bozza, Patrícia Torres ^a   Soares, Rodrigo Pedro ^a   Borges, Valéria Matos ^a,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Programa de Pós graduação em História   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85032571082     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-14229-8     Document Type: Article

References (67)

1. Herwaldt, B. L. Leishmaniasis. Lancet 354, 1191-1199 (1999).
2. de Assis, R. R., Ibraim, I. C., Nogueira, P. M., Soares, R. P. & Turco, S. J. Glycoconjugates in New World species of Leishmania: polymorphisms in lipophosphoglycan and glycoinositolphospholipids and interaction with hosts. Biochim Biophys Acta 1820, 1354-1365 (2012).
3. Descoteaux, A., Turco, S. J., Sacks, D. L. & Matlashewski, G. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. J Immunol 146, 2747-2753 (1991).
4. Giorgione, J. R., Turco, S. J. & Epand, R. M. Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani. Proc Natl Acad Sci USA 93, 11634-11639 (1996).
5. Desjardins, M. & Descoteaux, A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J Exp Med 185, 2061-2068 (1997).
6. Cunningham, A. C. Parasitic adaptive mechanisms in infection by leishmania. Exp Mol Pathol 72, 132-141 (2002).
7. Chawla, M. & Vishwakarma, R. A. Alkylacylglycerolipid domain of GPI molecules of Leishmania is responsible for inhibition of PKC-mediated c-fos expression. J Lipid Res 44, 594-600 (2003).
8. Delgado-Domínguez, J. et al. Leishmania mexicana lipophosphoglycan differentially regulates PKCalpha-induced oxidative burst in macrophages of BALB/c and C57BL/6 mice. Parasite Immunol 32, 440-449 (2010).
9. Kar, S., Ukil, A., Sharma, G. & Das, P. K. MAPK-directed phosphatases preferentially regulate pro- and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms. J Leukoc Biol 88, 9-20 (2010).
10. Forestier, C. L., Gao, Q. & Boons, G. J. Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate? Front Cell Infect Microbiol 4, 193 (2014).
11. Sacks, D. L., Pimenta, P. F., McConville, M. J., Schneider, P. & Turco, S. J. Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. J Exp Med 181, 685-697 (1995).
12. Soares, R. P. et al. Leishmania braziliensis: a novel mechanism in the lipophosphoglycan regulation during metacyclogenesis. Int J Parasitol 35, 245-253 (2005).
13. Coelho-Finamore, J. M. et al. Leishmania infantum: Lipophosphoglycan intraspecific variation and interaction with vertebrate and invertebrate hosts. Int J Parasitol 41, 333-342 (2011).
14. Flandin, J. F., Chano, F. & Descoteaux, A. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages. Eur J Immunol 36, 411-420 (2006).
15. Tuon, F. F. et al. Toll-like receptors and leishmaniasis. Infect Immun 76, 866-872 (2008).
16. Assis, R. R., Ibraim, I. C., Noronha, F. S., Turco, S. J. & Soares, R. P. Glycoinositolphospholipids from Leishmania braziliensis and L. infantum: modulation of innate immune system and variations in carbohydrate structure. PLoS Negl Trop Dis 6, e1543 (2012).
17. Nogueira, P. M. et al. Lipophosphoglycans from Leishmania amazonensis Strains Display Immunomodulatory Properties via TLR4 and Do Not Affect Sand Fly Infection. PLoS Negl Trop Dis 10, e0004848 (2016).
18. Rojas-Bernabé, A. et al. Leishmania mexicana lipophosphoglycan activates ERK and p38 MAP kinase and induces production of proinflammatory cytokines in human macrophages through TLR2 and TLR4. Parasitology 141, 788-800 (2014).
19. de Veer, M. J. et al. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol 33, 2822-2831 (2003).
20. Becker, I. et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol Biochem Parasitol 130, 65-74 (2003).
21. Ibraim, I. C. et al. Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages. Parasit Vectors 6, 54 (2013).
22. Daugschies, a & Joachim, a Eicosanoids in parasites and parasitic infections. Adv. Parasitol. 46, 181-240 (2000).
23. Tavares, N. M. et al. Understanding the mechanisms controlling Leishmania amazonensis infection in vitro: the role of LTB4 derived from human neutrophils. J Infect Dis 210, 656-666 (2014).
24. Afonso, L. et al. Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis. J Leukoc Biol 84, 389-396 (2008).
25. Tavares, N. et al. Degranulating Neutrophils Promote Leukotriene B4 Production by Infected Macrophages To Kill Leishmania amazonensis Parasites. J Immunol 196, 1865-1873 (2016).
26. Araújo-Santos, T. et al. Prostaglandin E2/leukotriene B4 balance induced by Lutzomyia longipalpis saliva favors Leishmania infantum infection. Parasit Vectors 7, 601 (2014).
27. Brandonisio, O. et al. Nitric oxide production by Leishmania-infected macrophages and modulation by cytokines and prostaglandins. Parassitologia 43(Suppl 1), 1-6 (2001).
28. Bhattacharjee, A. et al. Leishmania donovani-Induced Prostaglandin E2 Generation Is Critically Dependent on Host Toll-Like Receptor 2-Cytosolic Phospholipase A2 Signaling. Infect Immun 84, 2963-2973 (2016).
29. França-Costa, J. et al. Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis. J Infect Dis 211, 426-435 (2015).
30. Malta-Santos, H. et al. Resolvin D1 drives establishment of Leishmania amazonensis infection. Sci Rep 7, 46363 (2017).
31. Araújo-Santos, T. et al. Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance. Sci Rep 7, 4334 (2017).
32. Bozza, P. T., Bakker-Abreu, I., Navarro-Xavier, R. A. & Bandeira-Melo, C. Lipid body function in eicosanoid synthesis: An update. Prostaglandins Leukot. Essent. Fat. Acids 85, 205-213 (2011).
33. Rodríguez, N. E. et al. Lipid bodies accumulation in Leishmania infantum-infected C57BL/6 macrophages. Parasite Immunol, doi:https://doi.org/10.1111/pim.12443 (2017).
34. Aleshin, S., Strokin, M., Sergeeva, M. & Reiser, G. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses. Neurochemistry International 63, 322-330 (2013).
35. Almeida, P. E. et al. Differential TLR2 downstream signaling regulates lipid metabolism and cytokine production triggered by Mycobacterium bovis BCG infection. Biochim Biophys Acta 1841, 97-107 (2014).
36. 2-COX-2 inhibition, activating ROS production against Leishmania mexicana. Biomed Res Int 2013, 215283 (2013).
37. Paranaíba, L. F. et al. Leishmania enriettii: biochemical characterisation of lipophosphoglycans (LPGs) and glycoinositolphospholipids (GIPLs) and infectivity to Cavia porcellus. Parasit Vectors 8, 31 (2015).
38. Gazzinelli, R. T., Ropert, C. & Campos, M. A. Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. Immunol Rev 201, 9-25 (2004).
39. Moradin, N. & Descoteaux, A. Leishmania promastigotes: building a safe niche within macrophages. Front Cell Infect Microbiol 2, 121 (2012).
40. Ferguson, M. A. The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J Cell Sci 112(Pt 1), 2799-2809 (1999).
41. Silverman, J. M. et al. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J Cell Sci 123, 842-852 (2010).
42. Campos, J. H. et al. Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases. J Immunol Res 2015, 832057 (2015).
43. Guha-Niyogi, A., Sullivan, D. R. & Turco, S. J. Glycoconjugate structures of parasitic protozoa. Glycobiology 11, 45R-59R (2001).
44. Camargo, M. M. et al. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J Immunol 158, 5890-5901 (1997).
45. Charbeneau, R. P. & Peters-Golden, M. Eicosanoids: mediators and therapeutic targets in fibrotic lung disease. Clin Sci 108, 479-491 (2005).
46. Dai, L. et al. Lipoteichoic acid (LTA) and lipopolysaccharides (LPS) from periodontal pathogenic bacteria facilitate oncogenic herpesvirus infection within primary oral cells. PLoS One 9, e101326 (2014).
47. Iliev, D. B., Hansen, T., Jørgensen, S. M., Krasnov, A. & Jørgensen, J. B. CpG- and LPS-activated MAPK signaling in in vitro cultured salmon (Salmo salar) mononuclear phagocytes. Fish Shellfish Immunol 35, 1079-1085 (2013).
48. Elcombe, S. E. et al. Dectin-1 regulates IL-10 production via a MSK1/2 and CREB dependent pathway and promotes the induction of regulatory macrophage markers. PLoS One 8, e60086 (2013).
49. Feng, G. J. et al. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macr. J Immunol 163, 6403-6412 (1999).
50. Olekhnovitch, R. & Bousso, P. Induction, Propagation, and Activity of Host Nitric Oxide: Lessons from Leishmania Infection. Trends Parasitol 31, 653-664 (2015).
51. Miranda, M. M. et al. Nitric oxide and Brazilian propolis combined accelerates tissue repair by modulating cell migration, cytokine production and collagen deposition in experimental leishmaniasis. PLoS One 10, e0125101 (2015).
52. Maspi, N., Abdoli, A. & Ghaffarifar, F. Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review. Pathog Glob Heal. 110, 247-260 (2016).
53. Cunha, C. F. et al. Cytotoxic cell involvement in human cutaneous leishmaniasis: assessments in active disease, under therapy and after clinical cure. Parasite Immunol 38, 244-254 (2016).
54. Lima, M. H. F. et al. Leishmania infantum parasites subvert the host inflammatory response through the adenosine A2A receptor to promote the establishment of infection. Front. Immunol. 8, 1-12 (2017).
55. Odegaard, J. I. et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447, 1116-1120 (2007).
56. Adapala, N. & Chan, M. M. Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model. Lab Invest 88, 1329-1339 (2008).
57. Araújo, C. V. et al. A pparγ agonist enhances bacterial clearance through neutrophil extracellular trap formation and improves survival in sepsis. Shock 45, 393-403 (2016).
58. Lakshmi, S. P., Reddy, A. T., Banno, A. & Reddy, R. C. PPAR Agonists for the Prevention and Treatment of Lung Cancer. PPAR Res 2017, 8252796 (2017).
59. Fu, Y. et al. A novel pyrazole-containing indolizine derivative suppresses NF-κB activation and protects against TNBS-induced colitis via a PPAR-γ-dependent pathway. Biochem Pharmacol, doi:https://doi.org/10.1016/j.bcp.2017.03.013 (2017).
60. Zolezzi, J. M. et al. PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation. Biol Rev Camb Philos Soc, doi:https://doi.org/10.1111/brv.12320 (2017).
61. Assunção, L. S. et al. Schistosomal-derived lysophosphatidylcholine triggers M2 polarization of macrophages through PPARγ dependent mechanisms. Biochim Biophys Acta 1862, 246-254 (2017).
62. Almeida, P. E. et al. Mycobacterium bovis bacillus Calmette-Guérin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis. J Immunol 183, 1337-1345 (2009).
63. Chan, M. M., Adapala, N. & Chen, C. Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection. PPAR Res 2012, 796235 (2012).
64. Luz, N. F. et al. Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection. J Immunol 188, 4460-4467 (2012).
65. Soares, R. P. et al. Leishmania chagasi: lipophosphoglycan characterization and binding to the midgut of the sand fly vector Lutzomyia longipalpis. Mol Biochem Parasitol 121, 213-224 (2002).
66. Soares, R. P. et al. In Vitro Inhibition of Leishmania Attachment to Sandfly Midguts and LL-5 Cells by Divalent Metal Chelators, Anti-gp63 and Phosphoglycans. Protist 168, 326-334 (2017).
67. 2 production in murine macrophages. PLoS Negl. Trop. Dis. 4, e873 (2010).